Escolar Documentos
Profissional Documentos
Cultura Documentos
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
OBJECTIVES:
1. To discuss histamine, serotonin and ergot alkaloids
chemistry, pharmacokinetics and pharmacodynamics.
2. To identify drugs with action on histamine and serotonin
receptors.
3. To discuss its mode of action and clinical use.
4. To know associated drugs adverse effects and its
contraindications.
INTRODUCTION
Histamine, Serotonin (5-Hydroxytryptamine)
o
biologically active amines
o
function as neurotransmitters
o
found in non-neural tissues
o
have complex physiologic and pathologic effects
through multiple receptor subtypes
o
often released locally
o
constitute the autacoid drugs
HISTAMINE
o
o
o
o
o
o
o
o
o
o
o
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
b. basophils
without negative feedback:
a. lung mast cells
acts to limit the intensity of the allergic reaction in the
skin and blood.
local vasodilation and leakage of plasma containing
mediators of acute inflammation (complement, Creactive protein) and antibodies
chemotactic attraction for inflammatory cells such as:
- neutrophils
- eosinophils
- basophils
- monocytes
- lymphocytes
inhibits release of lysosome contents and several Tand B-lymphocyte functions (H2 or H4)
release of peptides from nerves in response to
inflammation (H3)
o
o
o
o
2.
3.
o
o
o
H3 receptor ~ H4 receptor (40% homology)
** Study this table!
o
o
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
and an
In the brain:
H1, H2- postsynaptic
H3- presynaptic
H1 receptors
present in endothelium, smooth muscle cells,
and nerve endings
H2 receptors
gastric mucosa, cardiac muscle cells, and
some immune cells
H 4 receptors
leukocytes in the bone marrow and
circulating blood
Activation of Receptors
o
H1 activation - present in endothelium, smooth
muscle cells, and nerve endings
o
Inc phosphoinotisol hydrolysis
o
Inc intracellular calcium muscle
contraction
o
Inc IP3
o
H2 activation gastric mucosa, cardiac muscle cells,
and some immune cells,
o
increases intracellular cyclic adenosine
monophosphate (cAMP) via Gs
o
H3 activation
o
Decrease transmitter release
* Increases appetite obesity
o
H4 activation - leukocytes in the bone marrow and
circulating blood
o
Chemotaxis on eosinophils and mast cells
Tissue and Organ System Effects of Histamine
o
Histamine exerts powerful effects on smooth and
cardiac muscle, on certain endothelial and
nerve cells, on the secretory cells of the
stomach, and on inflammatory cells.
Nervous System
o
Powerful stimulant of sensory nerve endings (H3,H1)
Pain
Itching
Acetylcholine
Amine
Peptide
Cardiovascular System
o
systolic and diastolic BP
Direct vasodilator action on arterioles and
precapillary sphincters
Flushing
Warmth
headache
HR
Stimulatory action on heart
Reflex tachycardia 2 to BP
* decrease blood volume, increase rounds of
circulation to compensate
o Vasodilation (small doses)- H1
release of nitric oxide from endothelium
BP reflex tachycardia
Can be antagonized by H1-receptor
antagonists alone
o Vasodilation (higher doses)- H2
cAMP
direct cardiac stimulation
*Anaphylactic rxns give epinephrine (physiologic antagonist)
not antihistamine
o
Edema- H1
Action of amine on H1 receptors in the
vessels of the microcirculation (esp
postcapillary vessels)
Separation of the endothelial cells
Urticaria (hives)
o
Direct Cardiac Effects
Increased contractility (H2)
Increased pacemaker rate (H2)
Decrease contractility in atrial smooth muscle
(H1)
*H1 located in AV node, result decrease transmission
arrythmia
*H2 SV node increase firing
o
Some of the cardiovascular signs and symptoms of
anaphylaxis are due to released histamine.
o
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
activation of H2 receptors on gastric
parietal cells
Metabolic Effects
o
Absence of H3 receptors in knockout mice
increased food intake
decreased energy expenditure
Obesity
insulin resistance
increased blood levels of leptin
increased blood levels of insulin
Not yet proven in humans but intensive research is
underway to determine whether H 3 agonists are useful
in the treatment of obesity
The Triple Response
o
Intradermal injection of histamine shows ff
characteristics:
Red spot
wheal
Flare
Other Effects
Histamine: local stimulation of peripheral pain nerve
endings via H 3 and H 1 receptors and play a role in
nociception in the central nervous system
Physiologic Antagonists
o
Epinephrine: smooth muscle actions opposite to
those of histamine
o
act at different receptors
o
i.e. epinephrine injection lifesaving in systemic
Anaphylaxis
Release inhibitors
o
reduce the degranulation of mast cells (antigen-IgE
interaction)
o
i.e. Cromolyn and nedocromil (tx: Asthma)
o
Beta 2 -adrenoceptor agonists also capable of
reducing
histamine release
Burimamide
o
an early candidate for H2 -blocking action,
and newer analogs
o
no effect on H1 , H2 , or H3 receptors
o
significant analgesic action in rodents via
CNS
o
analgesia comparable to opioids
o
no tolerance, respiratory depression,
constipation
Histamine: Toxicity
o
dose related
o
flushing
o
hypotension
o
tachycardia
o
headache
o
wheals
o
bronchoconstriction
o
gastrointestinal upset
o
symptoms similar to scombroid fish poisoning
histamine produced by bacterial action in the flesh of
the fish
o
should NOT be given to patients with asthma, active
ulcer disease or gastrointestinal bleeding
HISTAMINE ANTAGONISTS
thioperamide
clobenpropit
Clavillas, Peralta, Perez CA, Ramones, Usman
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
A. H1-RECEPTOR ANTAGONISTS
- Compounds that competitively block histamine or as
inverse
agonists at H 1 receptors used in the treatment of
allergic
conditions
3.
4.
5.
6.
7.
8.
Other actions
PHARMACODYNAMICS
2.
Second-generation H1 antagonists
o
allergic rhinitis
o
chronic urticaria
Motion
o
o
o
o
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
o
o
Ethanolamine H 1 antagonist
controversy
Toxicity
Sedation
antimuscarinic action
excitation and convulsions in children
postural hypotension
allergic responses
atropine overdosage
cardiac arrhythmias
astemizole or terfenadine
Drug Interactions
o
Lethal ventricular arrhythmias
o
early second-generation agents, terfenadine or
astemizole,
o
in combination with ketoconazole, itraconazole, or
macrolide, erythromycin, grapefruit
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
o
H 4 blockers
potential in chronic inflammatory conditions
in which eosinophils and mast cells play a
prominent role
pruritus, asthma, allergic rhinitis, and pain
conditions
B. H 2 -RECEPTOR ANTAGONISTS
o
drugs that blocked gastric acid secretion
o
no H 1 agonist or antagonist effects
o
very low toxicity
o
peptic ulcer disease
C. H 3 - & H 4 -RECEPTOR ANTAGONISTS
o
homology between the H 3 and H 4 receptors
o
no selective H 3 or H 4 ligands are presently available
for general clinical use
o
H 3 -selective ligands
sleep disorders, narcolepsy, obesity, and
cognitive and psychiatric disorders
Tiprolisant
Clavillas, Peralta, Perez CA, Ramones, Usman
PHARMACOLOGY
Chapter 16/Lecture #9
Histamine and Antihistaminics
Dr. TAC Abella July 22, 2014
MCQs:
1.
2.
3.
4.
5.
ABAAB